{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:22:46Z","timestamp":1769772166953,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":37,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["ZIA HG-000215"],"award-info":[{"award-number":["ZIA HG-000215"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ymgme.2025.109251","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:32:02Z","timestamp":1759541522000},"page":"109251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a radiographic vertebral severity score for evaluation of disease progression in alkaptonuria"],"prefix":"10.1016","volume":"146","author":[{"given":"Francis","family":"Rossignol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen S.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique B.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy C.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene J.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn R.","family":"Spears","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos R.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Murphey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Minn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Gahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy J.","family":"Introne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2025.109251_bb0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0021-9258(18)70560-7","article-title":"The nature of the defect in tyrosine metabolism in alcaptonuria","volume":"230","author":"La Du","year":"1958","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2025.109251_bb0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng0996-19","article-title":"The molecular basis of alkaptonuria","volume":"14","author":"Fernandez-Canon","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2025.109251_bb0015","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa021736","article-title":"Natural history of alkaptonuria","volume":"347","author":"Phornphutkul","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2025.109251_bb0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0304-4165(69)90068-3","article-title":"Oxidation of homogentisic acid to ochronotic pigment in connective tissue","volume":"177","author":"Zannoni","year":"1969","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2025.109251_bb0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/art.1780040304","article-title":"Studies of alcaptonuria: mechanisms of swelling of homogentisic acid-collagen preparations","volume":"4","author":"Milch","year":"1961","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ymgme.2025.109251_bb0030","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/jimd.12152","article-title":"Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease-a review","volume":"42","author":"Ranganath","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109251_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1357","article-title":"Assessment of thyroid function in patients with alkaptonuria","volume":"3","author":"Avadhanula","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ymgme.2025.109251_bb0040","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1086\/302027","article-title":"NTBC and alkaptonuria","volume":"63","author":"Anikster","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2025.109251_bb0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ymgme.2011.04.016","article-title":"A 3-year randomized therapeutic trial of nitisinone in alkaptonuria","volume":"103","author":"Introne","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109251_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108562","article-title":"Patient-reported outcomes and functional assessments of patients with Alkaptonuria in a 3-year Nitisinone treatment trial","volume":"143","author":"Spears","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109251_bb0055","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S2213-8587(20)30228-X","article-title":"Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial","volume":"8","author":"Ranganath","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.ymgme.2025.109251_bb0060","first-page":"336","article-title":"Lendenwirbels\u00e4ule und kreuzschmerzen","volume":"84","author":"Schober","year":"1937","journal-title":"Munch Med. Wochenschr."},{"key":"10.1016\/j.ymgme.2025.109251_bb0065","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s10067-015-3056-1","article-title":"Construct validity of clinical spinal mobility tests in ankylosing spondylitis: a systematic review and meta-analysis","volume":"35","author":"Castro","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.ymgme.2025.109251_bb0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","author":"A.T.S.C.o.P.S.f.C.P.F. Laboratories","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymgme.2025.109251_bb0075","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hec.4730020305","article-title":"The RAND 36-item health survey 1.0","volume":"2","author":"Hays","year":"1993","journal-title":"Health Econ."},{"key":"10.1016\/j.ymgme.2025.109251_bb0080","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/0269215506069475","article-title":"A systematic review of the human activity profile","volume":"21","author":"Davidson","year":"2007","journal-title":"Clin. Rehabil."},{"key":"10.1016\/j.ymgme.2025.109251_bb0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-3959(90)90068-O","article-title":"The Pain Disability Index: psychometric properties","volume":"40","author":"Tait","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.ymgme.2025.109251_bb0090","first-page":"MS23","article-title":"The SF-36 health survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity","volume":"37","author":"Kosinski","year":"1999","journal-title":"Med. Care"},{"key":"10.1016\/j.ymgme.2025.109251_bb0095","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1682\/JRRD.2003.07.0103","article-title":"Is the human activity profile a useful measure in people with knee osteoarthritis?","volume":"41","author":"Bennell","year":"2004","journal-title":"J. Rehabil. Res. Dev."},{"key":"10.1016\/j.ymgme.2025.109251_bb0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00002508-199409000-00005","article-title":"Relationship of the pain disability index (PDI) and the Oswestry disability questionnaire (ODQ) with three dynamic physical tests in a group of patients with chronic low-back and leg pain","volume":"10","author":"Gronblad","year":"1994","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.ymgme.2025.109251_bb0105","first-page":"2280","article-title":"Musculoskeletal findings and disability in alkaptonuria","volume":"33","author":"Perry","year":"2006","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ymgme.2025.109251_bb0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/NPT.0b013e318219308c","article-title":"Applying concepts of responsiveness to patient management in neurologic physical therapy","volume":"35","author":"Beninato","year":"2011","journal-title":"J. Neurol. Phys. Ther."},{"key":"10.1016\/j.ymgme.2025.109251_bb0115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjd.21686","article-title":"The challenges of clinical trials in rare diseases","volume":"187","author":"Mellerio","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymgme.2025.109251_bb0120","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/sim.5403","article-title":"Biomarkers and surrogate endpoints in clinical trials","volume":"31","author":"Fleming","year":"2012","journal-title":"Stat. Med."},{"key":"10.1016\/j.ymgme.2025.109251_bb0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","article-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance","volume":"4","author":"U.S.D.o. Health, F.D.A.C.f.D.E. Human Services, Research, U.S.D.o. Health, F.D.A.C.f.B.E. Human Services, Research, U.S.D.o. Health, F.D.A.C.f.D. Human Services, H. Radiological","year":"2006","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.ymgme.2025.109251_bb0130","series-title":"The Use of Patient-Reported Outcome Measures in Rare Diseases and Implications for Health Technology Assessment Patient","first-page":"485","volume":"14","author":"Whittal","year":"2021"},{"key":"10.1016\/j.ymgme.2025.109251_bb0135","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13023-014-0170-0","article-title":"A comparison of interventional clinical trials in rare versus non-rare diseases: an analysis of ClinicalTrials.gov","volume":"9","author":"Bell","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109251_bb0140","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11926-012-0305-z","article-title":"Low back pain and lumbar spine osteoarthritis: how are they related?","volume":"15","author":"Goode","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.ymgme.2025.109251_bb0145","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002422","article-title":"Radiological evolution of spinal disease in alkaptonuria and the effect of nitisinone","volume":"8","author":"Imrich","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.ymgme.2025.109251_bb0150","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/09638280400018411","article-title":"The Modified-Modified Schober Test for range of motion assessment of lumbar flexion in patients with low back pain: a study of criterion validity, intra- and inter-rater reliability and minimum metrically detectable change","volume":"27","author":"Tousignant","year":"2005","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.ymgme.2025.109251_bb0155","series-title":"SF-36 Health Survey: Manual and Interpretation Guide, Health Institute","author":"Ware","year":"1993"},{"key":"10.1016\/j.ymgme.2025.109251_bb0160","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/BRS.0b013e31822c8a7a","article-title":"Responsiveness and minimal clinically important change of the Pain Disability Index in patients with chronic back pain","volume":"37","author":"Soer","year":"2012","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.ymgme.2025.109251_bb0165","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/jep.12629","article-title":"Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: a systematic review","volume":"23","author":"Bohannon","year":"2017","journal-title":"J. Eval. Clin. Pract."},{"key":"10.1016\/j.ymgme.2025.109251_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70042","article-title":"Deep learning study of alkaptonuria spinal disease assesses global and regional severity and detects occult treatment status","volume":"48","author":"Flaharty","year":"2025","journal-title":"J. Inherit. Metab. Dis."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225002422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225002422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T19:50:17Z","timestamp":1769716217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225002422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1096719225002422"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109251","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a radiographic vertebral severity score for evaluation of disease progression in alkaptonuria","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109251"}}